Pages that link to "Item:Q5148609"
From MaRDI portal
The following pages link to Some recent developments in the design of adaptive clinical trials (Q5148609):
Displaying 15 items.
- Optimal Adaptive Designs for Binary Response Trials (Q65284) (← links)
- Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality (Q553031) (← links)
- On a two-treatment adaptive allocation rule for continuous response (Q713792) (← links)
- Implementing optimal allocation in clinical trials with multiple endpoints (Q729721) (← links)
- Response adaptive designs for phase II trials with binary endpoint based on context-dependent information measures (Q830089) (← links)
- Multiple-objective response-adaptive repeated measurement designs for clinical trials (Q1007498) (← links)
- An adaptive design for multi-arm clinical trials (Q1604614) (← links)
- Group-sequential response-adaptive designs for censored survival outcomes (Q2301063) (← links)
- Bayesian adaptive randomization with compound utility functions (Q2684688) (← links)
- Optimal and lead-in adaptive allocation for binary outcomes: A comparison of Bayesian methods (Q2979039) (← links)
- Compound optimal allocation for individual and collective ethics in binary clinical trials (Q3067018) (← links)
- On the inefficiency of the adaptive design for monitoring clinical trials (Q4455417) (← links)
- A New Class of Completely Self-Designing Clinical Trials (Q5122349) (← links)
- A Regulatory View on Adaptive/Flexible Clinical Trial Design (Q5122841) (← links)
- Adaptive Designs to Maximize Power in Clinical Trials with Multiple Treatments (Q5413553) (← links)